Thurston Springer Miller Herd & Titak Inc. Buys 146 Shares of Cardinal Health, Inc. (NYSE:CAH)

Thurston Springer Miller Herd & Titak Inc. grew its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 21.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 821 shares of the company’s stock after acquiring an additional 146 shares during the quarter. Thurston Springer Miller Herd & Titak Inc.’s holdings in Cardinal Health were worth $97,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of CAH. Point72 Asset Management L.P. purchased a new stake in Cardinal Health during the 2nd quarter valued at about $90,440,000. State Street Corp grew its holdings in shares of Cardinal Health by 4.6% during the third quarter. State Street Corp now owns 14,177,641 shares of the company’s stock valued at $1,566,913,000 after buying an additional 627,253 shares during the last quarter. Pacer Advisors Inc. increased its position in shares of Cardinal Health by 9.9% during the second quarter. Pacer Advisors Inc. now owns 4,099,082 shares of the company’s stock valued at $403,022,000 after acquiring an additional 370,181 shares in the last quarter. Two Sigma Advisers LP raised its holdings in Cardinal Health by 47.9% in the 3rd quarter. Two Sigma Advisers LP now owns 1,069,462 shares of the company’s stock worth $118,197,000 after acquiring an additional 346,362 shares during the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec lifted its position in Cardinal Health by 230.0% in the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 477,911 shares of the company’s stock valued at $52,819,000 after acquiring an additional 333,095 shares in the last quarter. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Analyst Ratings Changes

A number of analysts have commented on CAH shares. Citigroup lifted their target price on Cardinal Health from $120.00 to $129.00 and gave the stock a “neutral” rating in a report on Friday, January 10th. Barclays boosted their target price on Cardinal Health from $117.00 to $133.00 and gave the stock an “overweight” rating in a research report on Monday, November 4th. Bank of America raised shares of Cardinal Health from a “neutral” rating to a “buy” rating and raised their price target for the company from $132.00 to $145.00 in a report on Monday, January 6th. StockNews.com lowered shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Sunday, November 3rd. Finally, Mizuho assumed coverage on shares of Cardinal Health in a report on Wednesday, December 4th. They issued an “outperform” rating and a $139.00 target price on the stock. Four investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to MarketBeat, Cardinal Health has an average rating of “Moderate Buy” and a consensus price target of $133.29.

Cardinal Health Stock Performance

NYSE CAH opened at $126.27 on Friday. The business’s fifty day moving average is $120.75 and its 200 day moving average is $111.81. The company has a market capitalization of $30.56 billion, a PE ratio of 24.57, a price-to-earnings-growth ratio of 1.48 and a beta of 0.63. Cardinal Health, Inc. has a fifty-two week low of $93.17 and a fifty-two week high of $127.27.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Friday, November 1st. The company reported $1.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.62 by $0.26. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. The company had revenue of $52.28 billion during the quarter, compared to the consensus estimate of $50.90 billion. During the same period in the previous year, the company posted $1.73 EPS. The firm’s revenue was down 4.3% on a year-over-year basis. On average, sell-side analysts forecast that Cardinal Health, Inc. will post 7.82 EPS for the current year.

Cardinal Health Cuts Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd were given a dividend of $0.5056 per share. The ex-dividend date was Thursday, January 2nd. This represents a $2.02 annualized dividend and a dividend yield of 1.60%. Cardinal Health’s payout ratio is 39.30%.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.